Trial Involving CHOP Researchers Shows Drug Helps Pediatric Patients with Hypertrophic Cardiomyopathy
Published on
CHOP researchers participated in clinical trial that showed valsartan has a measurable benefit for patients with early-stage hypertrophic cardiomyopathy.